Biblioteca Humberto Rosselli Quijano
Resultado de la búsqueda
1 búsqueda de la palabra clave 'Trastorno Depresivo Mayor, Esquizofrenia, Psicología esquizofrénica, Sertralina.'
Refinar búsqueda Générer le flux rss de la recherche
Lien permanent de la recherche
Double-blind, placebo-controlled comparison of the efficacy of sertraline as treatment for a major depressive episode in patients with remitted schizophrenia / Donald E. Addington en Journal of Clinical Psychopharmacology, Año 2002 - Vol. 22 - No. 2 (Febrero)
[artículo]
Título : Double-blind, placebo-controlled comparison of the efficacy of sertraline as treatment for a major depressive episode in patients with remitted schizophrenia Tipo de documento: texto impreso Autores: Donald E. Addington, Autor ; Jean Addington, Autor ; Scott B. Patten, Autor Fecha de publicación: 2023 Artículo en la página: pp. 20-25 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno Depresivo Mayor, Esquizofrenia, Psicología esquizofrénica, Sertralina. Resumen: The effectiveness of selective serotonin reuptake inhibitors for depression in remitted schizophrenia has not been clearly demonstrated. A randomized, double-blind, prospective placebo-controlled study was performed of 48 subjects meeting DSM-IV criteria for both schizophrenia in remission and for a major depressive episode. Link: ./index.php?lvl=notice_display&id=31089
in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Febrero) . - pp. 20-25[artículo] Double-blind, placebo-controlled comparison of the efficacy of sertraline as treatment for a major depressive episode in patients with remitted schizophrenia [texto impreso] / Donald E. Addington, Autor ; Jean Addington, Autor ; Scott B. Patten, Autor . - 2023 . - pp. 20-25.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Febrero) . - pp. 20-25
Palabras clave: Trastorno Depresivo Mayor, Esquizofrenia, Psicología esquizofrénica, Sertralina. Resumen: The effectiveness of selective serotonin reuptake inhibitors for depression in remitted schizophrenia has not been clearly demonstrated. A randomized, double-blind, prospective placebo-controlled study was performed of 48 subjects meeting DSM-IV criteria for both schizophrenia in remission and for a major depressive episode. Link: ./index.php?lvl=notice_display&id=31089